Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. DEFA14A Proxy Proxy Materials
  2. DEF 14A Proxy Proxy Statement
  3. 4 Open-market sale Director sold 165,150 shares at $15.77 ($2,604,416)
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. 4 Open-market sale Director sold 630,374 shares at an average $16.14 ($10,174,788)
  6. SCHEDULE 13D/A Stake Beneficial Ownership Report
  7. 4 Open-market sale Director sold 737,989 shares at an average $16.10 ($11,883,340)
  8. SCHEDULE 13D/A Stake Beneficial Ownership Report
  9. 4 Open-market sale Director sold 620,133 shares at an average $16.50 ($10,233,811)
  10. 3 Insider Initial Statement of Ownership
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. 4 Open-market sale Director sold 849,257 shares at an average $17.10 ($14,518,963)
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. 3 Insider Initial Statement of Ownership
  15. SCHEDULE 13D/A Stake Beneficial Ownership Report
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  19. SCHEDULE 13D/A Stake Beneficial Ownership Report
  20. SCHEDULE 13G/A Stake Statement of Beneficial Ownership

Page 3 of 24 · 464 filings